Put your glucose management on auto mode

Smartphone based therapy management is the future of diabetes treatment. Combine the mylife YpsoPump insulin pump, the mylife CamAPS FX mobile application and the Dexcom G6 or FreeStyle Libre 3 Continuous Glucose Monitoring (CGM) System for an automated insulin delivery system managed directly from your smartphone. The integration of automated insulin delivery into the mylife YpsoPump system portfolio allows you time away from your diabetes and more freedom to do what you love doing.

mylife Loop - CamAPS FX

Prof. Roman Hovorka, developer of the mylife CamAPS FX app, explains how the mylife CamAPS FX algorithm learns.

How mylife Loop works

For automated insulin delivery with the mylife YpsoPump, you need the mylife CamAPS FX app and the Dexcom G6 or FreeStyle Libre 3 CGM. Connect the mylife CamAPS FX app to the insulin pump and sensor. The sensor sends glucose data every minute (FreeStyle Libre 3) or every five minutes (Dexcom G6) to the mylife CamAPS FX app. Based on those readings, the app adjusts insulin delivery on the insulin pump every eight to twelve minutes to prevent low and high glucose levels.

The mylife CamAPS FX app is personalised and adaptive; it constantly learns and quickly adapts to ever changing insulin needs. It adjusts to diurnal and day-to-day variations in insulin requirements and compensates for over and under-dosing of the meal bolus. For increased privacy and convenience, you are able to deliver a meal bolus directly from your smartphone.

The mylife CamAPS FX app is approved for people with type 1 diabetes aged one year and over, including pregnant women. Approved for people with type 1 diabetes aged two years and over when used in combination with Dexcom G6 or aged four years and over when used in combination with FreeStyle Libre 3.

mylife CamAPS FX - Screen Overview

Navigation (Home screen)

Home Screen

Detailed graph (to view the detailed graph, rotate the home screen into landscape configuration or tap the "screen rotation" icon).

Specifications

Age limit:
The mylife CamAPS FX app is approved for people with type 1 diabetes aged one year and over, including pregnant women. Approved for people with type 1 diabetes aged two years and over when used in combination with Dexcom G6 or aged four years and over when used in combination with FreeStyle Libre 3.
Phone compatibility:
Android smartphones compatible with Dexcom: www.dexcom.com/compatibility

Android smartphones compatible with FreeStyle Libre 3: https://www.diabetescare.abbott/support/manuals.html (see document “Mobile Device & OS Compatibility”). If using a FreeStyle Libre 3 sensor, please ensure you have an Android smart device with NFC (near field communication).

For Companion remote monitoring only: Android smartphones running OS 8 and above.
Compatible CGM (Continuous Glucose Monitoring) sensors:
Dexcom G6: factory calibrated, blood glucose tests only needed in exceptional cases (consult the Dexcom G6 Instructions for Use).
FreeStyle Libre 3: no calibration neccessary, blood glucose tests only needed in exceptional cases (consult the FreeStyle Libre 3 Instructions for Use).
Total daily dose (TDD) and weight range:
5-350 units/day total daily dose (TDD)
10-300 kg weight
Algorithm:
Treat to target.
Predictive control: the algorithm calculates the insulin requirement for the next 2.5-4 hours.
Adaptive model: insulin delivery is adjusted every 8-12 minutes.
Learning:
Continually adjusting insulin delivery every 8-12 minutes based on CGM glucose data received every minute (FreeStyle Libre 3) or every 5 minutes (Dexcom G6). Learning from previous insulin delivery and meal bolus information to adapt to diurnal, day-to-day as well as post-meal insulin needs.
Glucose target:
Default target: 5.8 mmol/L (104 mg/dL)
Customisable personal target: 4.4-11.0 mmol/L (80-198 mg/dL)
Data sharing:
Yes, via:
mylife CamAPS FX app on smartphone: generation and export of PDF reports including glucose statistics, insulin statistics, "Auto mode" and alert statistics, information about settings and weekly overviews. Internet connectivity is required to generate PDF reports.

Glooko: automated data upload from the mylife CamAPS FX app to the Glooko platform to share data with healthcare professionals. Internet connectivity is required to share data with Glooko.
Remote monitoring:
Yes, via:
Companion remote monitoring: the mylife CamAPS FX app allows user's data to be shared with up to 10 "companions". Remote monitoring is integrated into the app and therefore both, user and "companion", use the mylife CamAPS FX app. CGM data, insulin data and other data as well as alerts are mirrored in the "companion's" mylife CamAPS FX app. Internet connectivity is required to share data with "companions".

SMS based remote monitoring: the mylife CamAPS FX app supports SMS based remote monitoring. All app generated alarms and alerts will be sent via SMS message to up to 5 "followers". A SIM card is required to send SMS messages to "followers".

Please note that it is possible to use the Companion remote monitoring and SMS based remote monitoring at the same time.
Discrete bolusing:
Yes, via mylife CamAPS FX app on smartphone.
Bolus calculator:
Yes, via mylife CamAPS FX app on smartphone.
Additional features:
“Boost” and “Ease-off” modes
Slowly absorbed meal function